Fairfield, Bush & Co.
Source: SEC Form 13F · as of Mar 2026Fairfield, Bush & Co. holds 13 biotech & pharma companies tracked by BioSniper, totaling $18.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$18.3M
| Company | Shares | Value |
|---|---|---|
| NVSNovartis AG | 19,344 | $3.0M |
| LLYELI LILLY & Co | 2,837 | $2.6M |
| MRKMerck & Co., Inc. | 21,247 | $2.6M |
| PMPhilip Morris International Inc | 13,379 | $2.2M |
| JNJJOHNSON & JOHNSON | 8,942 | $2.2M |
| ABBVAbbVie Inc. | 6,755 | $1.5M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,532 | $1.2M |
| AMGNAMGEN INC | 2,946 | $1.0M |
| PFEPFIZER INC | 24,553 | $689K |
| NVONovo Nordisk A/S | 16,096 | $592K |
| GILDGILEAD SCIENCES, INC. | 2,117 | $295K |
| GEHCGE HealthCare Technologies Inc. | 4,011 | $286K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 611 | $273K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.